Nebula Research & Development’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-144,365
| Closed | -$371K | – | 1214 |
|
|
2024
Q2 | $371K | Sell |
144,365
-30,502
| -17% | -$78.4K | 0.06% | 522 |
|
|
2024
Q1 | $860K | Buy |
174,867
+69,572
| +66% | +$342K | 0.19% | 184 |
|
|
2023
Q4 | $926K | Buy |
+105,295
| New | +$926K | 0.28% | 86 |
|
|
2023
Q3 | – | Sell |
-11,619
| Closed | -$294K | – | 689 |
|
|
2023
Q2 | $294K | Buy |
+11,619
| New | +$294K | 0.22% | 213 |
|